A study of some genes related to serotoninergic and dopaminergic systems and auditory evoked-potentials (P300) in patients with schizophrenia and spectrum disorders and their first-degree relatives

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 105, Issue 10, 2005, Pages 35-41

  Golimbet, V E ^a   Lebedeva, I S ^a   Gritsenko, I K ^a   Korovaitseva, G I ^a   Alfimova, M V ^a   Lezheiko, T V ^a   Abramova, L I ^a   Kaleda, V G ^a   Ebstein, R P ^a   Rogaev, E I ^a  

^a NONE

Author keywords

Dopamine; Evoked potentials; Gene polymorphism; P300; Relatives; Schizophrenia; Serotonin

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; PRIMER DNA; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PROMOTER REGION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; DNA PRIMERS; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D4; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33644674217     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Anokhin A.P., Todorov A.A., Madden P.A. et al. Brain event-related potentials, dopamine D2 receptor gene polymorphism, and smoking. Genet Epidemiol 1999; 1: 17: Suppl 1: 37-42.
2. Blackwood D.H., Glabus M.F., Dunan J. et al. Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300. Br J Psychiat 1999; 175: 357-366.
3. Blum K., Braverman E.R., Dinardo M.J. et al. Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor Al allele. Pharmacogenetics 1994; 4: 6: 313-322.
4. Bramon E., Rabe-Hesketh S., Sham P. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 2004; 70: 2-3: 315-329.
5. Chen T.J., Yu Y.W., Chen J. Y. et al. Association analysis of two dopamine D2 receptor gene polymorphisms and P300 event-related potential in depressive patients. Neuropsychobiology 2002; 46: 3: 141-144.
6. d'Ardhuy X.L., Boeijinga P.H., Renault B. et al. Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential. Neuropsychobiology 1999; 40: 4: 207-213.
7. Egan M.F., Duncan CC, Suddath R.L. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia. Schizophr Res 1994; 11: 3: 259-271.
8. Egan M.F., Goldberg T.E., Gscheidle T. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiat 2001; 50: 2: 98-107.
9. Fallgatter A.J., Herrmann M.J., Roemmler J. Allelic variation of serotonin transporter function modulates the brain electrical response for error processing. Neuropsychopharmacology 2004; 29: 8: 1506-1511.
10. Fossella J., Sommer T., Fan J. et al. Assessing the molecular genetics of attention networks. BMC Neuroscience 2002; 3: 14-21.
11. Frangou S., Sharma T., Alarcon G. et al. The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia. Schizophr Res 1997; 23: 1: 45-53.
12. Gallinat J., Bajbouj M., Sander T. et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiat 2003; 54: 1: 40-48.
13. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiat 2003; 160: 3: 469-476.
14. Goldberg T.E., Egan M.F., Gscheidle T. et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Vall58Met genotype and schizophrenia. Arch Gen Psychiat 2003; 60: 9: 889-896.
15. Gritsenko I.K., Golimbet V.E., Abramova L.I. et al. An associative study of DRD4 gene polymorphisms in promoter region and clinical features of schizophrenic patients. Am J Med Genet 2004; 130B: 1: 86.
16. Halgren E., Marinkovic K., Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol 1998; 106: 2: 156-164.
17. Hansenne M., Ansseau M. P300 event-related potential and serotonin-1A activity in depression. Eur Psychiat 1999; 14: 3: 143-147.
18. Higashima M., Nagasawa T., Kawasaki Y. et al. Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies. Schizophr Res 2003; 59: 2-3: 147-157.
19. Jeon Y.W., Polich J. Meta-analysis of P300 and schizophrenia: patients, paradigms, and practical implications. Psychophysiology 2003; 40: 5: 684-701.
20. Kidogami Y., Yoneda H., Asaba H, et al. P300 in first degree relatives of schizophrenics. Schizophr Res 1991; 6: 1: 9-13.
21. Malhotra A.K., Kestler L.J., Mazzanti C. et al. 2A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiat 2000; 159: 4: 652-654.
22. Muller T.J., Kalus P., Strik W.K. The neuropsychological meaning of auditory P300 in subtypes of schizophrenia. Wld J Biol Psychiat 2001; 2: 9-17.
23. Nieman D.H., Koelman J.H., Linszen D.H. et al. Clinical and neuropsychological correlates of the P300 in schizophrenia. Schizophr Res 2002; 55: 1-2: 105-113.
24. Noble E.P., Berman S.M., Ozkaragoz T.Z. et al. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet 1994; 54: 4: 658-668.
25. Okuyama Y., Ishiguro H, Nankai M. et al. Identification of a polymorphism un the promoter region of DRD4 associated with the human novelty seeking personality trait. Mol Psychiat 2000; 5: 64-69.
26. th edition, Williams&Wilkins, A Waverly Company 1999; 1073-1085.
27. Pritchard W.S. Cognitive event-related potentials correlates of schizophrenia. Psychol Bull 1986; 100: 43-66.
28. Rosa A., Peralta V., Cuesta M.J. et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiat 2004; 161: 6: 1110-1112.
29. Seeman P., Guan H.C., Van Tol H.H. Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365: 6445: 441-445.
30. Shifman S., Bronstein M., Sternfeld M. et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 6: 1296-1302.
31. Stefanis N.C., Bresnick J.N., Kerwin R.W. et al. Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Brain Res Mol Brain Res 1998; 53: 1-2: 112-119.
32. Stefansson S.B., Jonsdotiir T.J. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication. Biol Psychiat 1996; 40: 1: 19-27.
33. Tsai S.J., Yu Y.W., Chen T.J. et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003; 338: 2: 123-126.
34. Turetsky B., Colbath E.A., Gur R.E. P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stability and relationship to symptom change. Biol Psychiat 1998; 43: 1: 31-39.
35. Weinberger D.R., Egan M.F., Bertolino A. et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiat 2001; 50: 11: 825-844.
36. Yu Y.W., Tsai S.J., Yang K.H. et al. Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N amplitude in schizophrenics treated with clozapine. Neuropsychobiology 2001; 43: 2: 79-82.